A mouse model of the human Fragile X syndrome I304N mutation.
about
FMRP stalls ribosomal translocation on mRNAs linked to synaptic function and autismFragile x syndromeModifying behavioral phenotypes in Fmr1KO mice: genetic background differences reveal autistic-like responses.RNA protein interaction in neuronsThe FMRP regulon: from targets to disease convergenceThe unstable repeats--three evolving faces of neurological diseaseTherapeutic Strategies in Fragile X Syndrome: From Bench to Bedside and BackStructure-function studies of FMRP RGG peptide recognition of an RNA duplex-quadruplex junctionModeling Fragile X Syndrome Using Human Pluripotent Stem CellsNuclear Fragile X Mental Retardation Protein is localized to Cajal bodiesIndependent role for presynaptic FMRP revealed by an FMR1 missense mutation associated with intellectual disability and seizuresFmrp Interacts with Adar and Regulates RNA Editing, Synaptic Density and Locomotor Activity in ZebrafishA Nondegenerate Code of Deleterious Variants in Mendelian Loci Contributes to Complex Disease RiskFrom FMRP function to potential therapies for fragile X syndrome.Comprehensive neurocognitive endophenotyping strategies for mouse models of genetic disordersAutomated multi-day tracking of marked mice for the analysis of social behaviourFragile X mental retardation protein regulates translation by binding directly to the ribosomeHistone deacetylases suppress CGG repeat-induced neurodegeneration via transcriptional silencing in models of fragile X tremor ataxia syndrome.Meeting at the crossroads: common mechanisms in Fragile X and Down syndromeIncreasing our understanding of human cognition through the study of Fragile X Syndrome.A presynaptic role for FMRP during protein synthesis-dependent long-term plasticity in Aplysia.Concise review: Fragile X proteins in stem cell maintenance and differentiationProgrammed cell death is impaired in the developing brain of FMR1 mutantsBehavioral profiles of mouse models for autism spectrum disorders.Heads-up: new roles for the fragile X mental retardation protein in neural stem and progenitor cells.Defects in translational regulation contributing to human cognitive and behavioral disease.New perspectives on the biology of fragile X syndromeRNA-binding proteins involved in RNA localization and their implications in neuronal diseases.Cytoplasmic RNA-binding proteins and the control of complex brain function.Role of a redox-based methylation switch in mRNA life cycle (pre- and post-transcriptional maturation) and protein turnover: implications in neurological disorders.Fragile X mental retardation protein and synaptic plasticityThe translation of translational control by FMRP: therapeutic targets for FXS.Fragile X syndrome: a preclinical review on metabotropic glutamate receptor 5 (mGluR5) antagonists and drug development.RNA binding proteins: a common denominator of neuronal function and dysfunction.Regulation of monocyte induced cell migration by the RNA binding protein, FXR1.Integrated transcriptome analysis of human iPS cells derived from a fragile X syndrome patient during neuronal differentiation.Screening the Molecular Framework Underlying Local Dendritic mRNA Translation.Systematic mapping of fragile X granules in the mouse brain reveals a potential role for presynaptic FMRP in sensorimotor functions.A MicroRNA Profile in Fmr1 Knockout Mice Reveals MicroRNA Expression Alterations with Possible Roles in Fragile X Syndrome.Modulation of dADAR-dependent RNA editing by the Drosophila fragile X mental retardation protein.
P2860
Q24631425-2C402787-AC38-44D4-AC1F-D82DBBD318B8Q24633000-21744E5D-A548-40CC-8022-643E0928400FQ24634270-E4848BE2-2845-48DC-A281-1A0795F1B6D8Q27001674-AB613CE6-94D5-4DDB-B525-84B22FD56EF3Q27014002-20F3199A-F275-4DBD-BFA4-040AF50AEC3EQ27025923-D9070B96-432C-461E-B6D2-26C060B2612EQ27337360-C30C1B41-3A35-4D50-98C0-5B657870ED97Q27666251-7376B0A8-BF7E-4F43-986F-6B5CCC4AAC89Q28080022-11B7A1C9-9BF7-40E0-8BA1-6DF6FCF73135Q28115047-4C01D4FD-5D27-43FA-B7BF-7AA54C0618ADQ28115339-8A158109-C922-4AEA-8B93-51F2EC67D404Q28551350-A465D89D-53EC-4040-93E0-A060310D5DDEQ30002401-D4FBA6CE-E5B3-48C4-B6A1-0FBA3BFB0FADQ30410502-D40C1F2E-91CC-480B-9FB2-D2AFA4AD760EQ30458768-B0FC26C5-2266-4888-9326-DAD2B0FFBE06Q30544057-1100E6BC-47DE-48DA-ABC6-1623FB0A932BQ33605244-87C48A16-3927-4A03-AD59-1181C1129A13Q33775485-D8B68EC0-51D9-4EEA-A194-76EF72DCF3E0Q33874584-3E77CEDB-E458-4988-B6E9-F97821AAB543Q34435526-8C6E5C9E-8C59-45BB-A759-41BA15498604Q34505148-966C38F0-9667-4542-B485-786B6809491BQ34632480-FBD692D2-437E-4B4C-91D5-A80760ED78F3Q37425105-66722C0D-CFC5-495E-B7D6-97B2A2EECCC1Q37844007-6CD78853-2E06-4A64-A6A1-DE1763C1F758Q37853118-7C69E4DF-6A2D-4083-972A-9AECFAD65074Q37901907-4DA8AF9A-1DC8-4265-880D-9E1E8ABE2838Q37989764-169F2AB6-50A5-4DBD-9E39-31D6024EC7A2Q38019564-3515A8DD-F702-44AC-839F-60088C94852DQ38020814-A3B1D56D-DC7D-4C73-87BB-E66EADF13027Q38022239-3557B725-5DF0-47DC-A4C9-AE3B323F4FAEQ38097197-DCC042B2-A4BA-48B1-8139-9A79092ECCDDQ38098906-E1B2FD28-A367-4B72-B636-609067642626Q38162720-4949AD23-D1E1-45BF-9F87-8F3E48CE53B9Q38222976-08D7049C-8490-4BDC-8003-3A2B392FD32CQ38292326-D5A5CCDF-2E90-487E-A811-D7361ECC9B05Q38441936-9015B3B8-2AFC-416C-8077-C99A0EBD8896Q38558121-7C0500C1-A491-4A0B-AF52-1DCF0C24963BQ38947125-2852C448-842D-466F-AD17-2D1A9D371389Q38987390-B3345D5A-E7AD-45F2-BFC2-27C9DCBA764CQ39430364-16CB0CFB-AF14-4CC6-AB98-5DD6D68643E5
P2860
A mouse model of the human Fragile X syndrome I304N mutation.
description
2009 nî lūn-bûn
@nan
2009 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
A mouse model of the human Fragile X syndrome I304N mutation.
@ast
A mouse model of the human Fragile X syndrome I304N mutation.
@en
type
label
A mouse model of the human Fragile X syndrome I304N mutation.
@ast
A mouse model of the human Fragile X syndrome I304N mutation.
@en
prefLabel
A mouse model of the human Fragile X syndrome I304N mutation.
@ast
A mouse model of the human Fragile X syndrome I304N mutation.
@en
P2093
P2860
P1433
P1476
A mouse model of the human Fragile X syndrome I304N mutation.
@en
P2093
Corinne M Spencer
Elena D Nosyreva
Elizabeth F Stone
Jennifer C Darnell
Julie B Zang
Kimberly M Huber
Kiran Musunuru
Lenora J Volk
Lisa A Yuva-Paylor
Richard Paylor
P2860
P304
P356
10.1371/JOURNAL.PGEN.1000758
P577
2009-12-11T00:00:00Z